ProShare Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52K | Sell |
|
|||||
|
2025
Q1 | $143K | Sell |
|
|||||
|
2024
Q4 | $287K | Buy |
|
|||||
|
2024
Q3 | $329K | Buy |
|
|||||
|
2024
Q2 | $302K | Sell |
|
|||||
|
2024
Q1 | $475K | Buy |
|
|||||
|
2023
Q4 | $484K | Buy |
|
|||||
|
2023
Q3 | $257K | Buy |
|
|||||
|
2023
Q2 | $248K | Buy |
|
|||||
|
2023
Q1 | $207K | Sell |
|
|||||
|
2022
Q4 | $258K | Buy |
|
|||||
|
2022
Q3 | $167K | Buy |
|
|||||
|
2022
Q2 | $139K | Sell |
|
|||||
|
2022
Q1 | $229K | Sell |
|
|||||
|
2021
Q4 | $394K | Sell |
|
|||||
|
2021
Q3 | $562K | Sell |
|
|||||
|
2021
Q2 | $961K | Buy |
|
|||||
|
2021
Q1 | $814K | Buy |
|
|||||
|
2020
Q4 | $881K | Buy |
|
|||||
|
2020
Q3 | $299K | Sell |
|
|||||
|
2020
Q2 | $281K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $340K | Sell |
|
|||||
|
2019
Q3 | $199K | Sell |
|
|||||
|
2019
Q2 | $258K | Sell |
|
|||||
|
2019
Q1 | $304K | Buy |
|
|||||
|
2018
Q4 | $233K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $177K | Sell |
|
|||||
|
2016
Q2 | $162K | Buy |
|
|||||
|
2016
Q1 | $144K | Sell |
|
|||||
|
2015
Q4 | $241K | Buy |
|